Synthetic Human Secretin in Children With Autism and Gastrointestinal Dysfunction

• Status: Terminated
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to determine the effect of multiple doses of secretin on autism.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Repligen Corporation
• Treatments: Secretin

Criteria

• Autism

• Gastrointestinal dysfunction